The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'April, 2019'. If you still can't find what you are looking for, try using the search box.
TBAT's new office is located at Milton Park Innovation Centre, a thriving science and technology hub. Oxford and the South East in general, is flourishing with innovative and cutting-edge businesses and we're thrilled to now be located at the centre of that; while also maintaining our presence in the East Midlands.
Read the rest of entry »
XerumFree™ has been developed taking into account what is missing in traditional basal cell culture media to sustain growth of all cell types, which is a nutritional approach at the cellular level.
Nanopore Tech Tour 2019 is a nanopore-sequencing conference featuring scientific talks, poster sessions, plus the opportunity to learn more about the latest technology updates. From library preparation and sequencing live demos, to breakout sessions on bioinformatics tools for nanopore data.
OBN Members are invited to vote in our General Meeting on Monday 29 April 2019, 15:30 - 16:30 hrs at etc.venues 155 Bishopsgate, London, EC2M 3YD.
MARLOW & NOTTINGHAM, UK. -- April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.
Located in the heart of Oxford’s booming health and data sciences community and opening in late April, the new Wood Centre for Innovation (WCFI) has been developed to provide bespoke innovation space for entrepreneurs, start-up and grow-on tech companies particularly working in life science research, med tech or digital health.
Funds will accelerate commercialization of InVisionFirstTM-Lung Liquid Biopsy test and the development of the InVision® liquid biopsy platform into new indications.
(Oxford, UK and Conshohocken, US, 3 April 2019) Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its development program, the investigation of tebentafusp (IMCgp100) for the treatment of patients who are HLA-A*0201-positive with previously untreated, metastatic uveal melanoma (mUM).
Please take a look at the next edition of our OBN Monthly Newsletter. We hope that you find it interesting and useful.
Southampton, UK, April 3, 2019 – VivoPlex Group Ltd, a leader in real time and accurate intra-uterine monitoring, has established an international Scientific Advisory Board to help optimise the development and launch of its uterine biosensor. The Board, chaired by VivoPlex co-founder Professor Nicholas Macklon, comprises five experts across human reproduction and fertility technology.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.